Back to Journals » Drug Design, Development and Therapy » Volume 15

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Total article views   HTML views PDF downloads Totals
6,043 Dovepress* 5,221+ 642 5,863
PubMed Central* 822 284 1,106
Totals 6,043 926 6,969
*Since 27 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar